VantAI
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
116 E 16th St Fl 12, New York, New York,...Phone Number
+54 3424695740Website
www.vant.aiRevenue
$5.6 MillionIndustry
About VantAI
VantAI is a company focused on generative AI-enabled drug discovery, aiming to revolutionize medicine by making protein interactions programmable. They offer an integrated discovery platform with technologies for inducers, modulators, and blockers, particularly highlighted by the launch of Neo-1, the first AI model for therapeutic design. The company works in collaboration with industry leaders such as Blueprint Medicines to advance induced proximity drug discovery. VantAI seeks to attract professionals who are eager to tackle complex scientific challenges through innovative AI applications.Explore more
VantAI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to VantAI
Compare insights from companies similar to VantAI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
VantAI
$5.6M
11-50
Private
-
2019
AG
Alexander GoncearencoSenior Principal and Director Head Of Computational Biology
VantAI Tech Stack
A closer look at the technologies used by VantAI
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding VantAI
Sign Up For FreeTo access detailed company insights
VantAI is a company focused on generative AI-enabled drug discovery, aiming to revolutionize medicine by making protein interactions programmable. They offer an integrated discovery platform with technologies for inducers, modulators, and blockers, particularly highlighted by the launch of Neo-1, the first AI model for therapeutic design. The compa... Read More
